735 related articles for article (PubMed ID: 23333900)
21. Micro-scale prediction method for API-solubility in polymeric matrices and process model for forming amorphous solid dispersion by hot-melt extrusion.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2016 Oct; 107():40-8. PubMed ID: 27349807
[TBL] [Abstract][Full Text] [Related]
22. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
23. Comparison between hot-melt extrusion and spray-drying for manufacturing solid dispersions of the graft copolymer of ethylene glycol and vinylalcohol.
Guns S; Dereymaker A; Kayaert P; Mathot V; Martens JA; Van den Mooter G
Pharm Res; 2011 Mar; 28(3):673-82. PubMed ID: 21104299
[TBL] [Abstract][Full Text] [Related]
24. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
25. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
26. Preparation of pharmaceutical cocrystal formulations via melt mixing technique: A thermodynamic perspective.
Barmpalexis P; Karagianni A; Nikolakakis I; Kachrimanis K
Eur J Pharm Biopharm; 2018 Oct; 131():130-140. PubMed ID: 30092346
[TBL] [Abstract][Full Text] [Related]
27. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
[TBL] [Abstract][Full Text] [Related]
28. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
Li S; Tian Y; Jones DS; Andrews GP
AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
[TBL] [Abstract][Full Text] [Related]
29. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
[TBL] [Abstract][Full Text] [Related]
30. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
[TBL] [Abstract][Full Text] [Related]
31. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
32. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
[TBL] [Abstract][Full Text] [Related]
33. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
34. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement.
Hu XY; Lou H; Hageman MJ
Int J Pharm; 2018 Dec; 552(1-2):154-163. PubMed ID: 30268849
[TBL] [Abstract][Full Text] [Related]
35. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy.
Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T
Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540
[TBL] [Abstract][Full Text] [Related]
36. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
Xi L; Song H; Wang Y; Gao H; Fu Q
AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
[TBL] [Abstract][Full Text] [Related]
37. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
Andrews GP; AbuDiak OA; Jones DS
J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
[TBL] [Abstract][Full Text] [Related]
39. Processing thermally labile drugs by hot-melt extrusion: The lesson with gliclazide.
Huang S; O'Donnell KP; Delpon de Vaux SM; O'Brien J; Stutzman J; Williams RO
Eur J Pharm Biopharm; 2017 Oct; 119():56-67. PubMed ID: 28583588
[TBL] [Abstract][Full Text] [Related]
40. Hot melt extrusion based solid solution approach: Exploring polymer comparison, physicochemical characterization and in-vivo evaluation.
Fule R; Paithankar V; Amin P
Int J Pharm; 2016 Feb; 499(1-2):280-294. PubMed ID: 26746801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
